Pleomorphic Variant Mantle Cell Lymphoma
3 clinical trials · Condition
◉ Watch Pleomorphic Variant Mantle Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma (NCT05861050) | City of Hope Medical Center | 2023-08-10 |
| Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT03946878) | M.D. Anderson Cancer Center | 2019-08-13 |
| Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT02427620) | M.D. Anderson Cancer Center | 2015-06-03 |
Track Pleomorphic Variant Mantle Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.